company background image
002750 logo

Kunming Longjin Pharmaceutical SZSE:002750 Stock Report

Last Price

CN¥1.69

Market Cap

CN¥676.8m

7D

14.2%

1Y

-81.6%

Updated

06 Jul, 2024

Data

Company Financials

Kunming Longjin Pharmaceutical Co., Ltd.

SZSE:002750 Stock Report

Market Cap: CN¥676.8m

002750 Stock Overview

Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China.

002750 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Kunming Longjin Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kunming Longjin Pharmaceutical
Historical stock prices
Current Share PriceCN¥1.69
52 Week HighCN¥12.50
52 Week LowCN¥1.43
Beta0.24
11 Month Change-11.98%
3 Month Change-76.59%
1 Year Change-81.59%
33 Year Change-77.10%
5 Year Change-85.00%
Change since IPO-66.80%

Recent News & Updates

Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet

Jun 30
Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet

Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%

Apr 26
Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%

Recent updates

Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet

Jun 30
Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet

Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%

Apr 26
Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%

We're Not Very Worried About Kunming Longjin Pharmaceutical's (SZSE:002750) Cash Burn Rate

Apr 17
We're Not Very Worried About Kunming Longjin Pharmaceutical's (SZSE:002750) Cash Burn Rate

Revenues Not Telling The Story For Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) After Shares Rise 29%

Mar 08
Revenues Not Telling The Story For Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) After Shares Rise 29%

Shareholder Returns

002750CN PharmaceuticalsCN Market
7D14.2%1.0%-1.4%
1Y-81.6%-15.1%-18.4%

Return vs Industry: 002750 underperformed the CN Pharmaceuticals industry which returned -15.1% over the past year.

Return vs Market: 002750 underperformed the CN Market which returned -18.4% over the past year.

Price Volatility

Is 002750's price volatile compared to industry and market?
002750 volatility
002750 Average Weekly Movement9.0%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.6%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 002750's share price has been volatile over the past 3 months.

Volatility Over Time: 002750's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
1996285n/awww.longjin.com.cn

Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business.

Kunming Longjin Pharmaceutical Co., Ltd. Fundamentals Summary

How do Kunming Longjin Pharmaceutical's earnings and revenue compare to its market cap?
002750 fundamental statistics
Market capCN¥676.85m
Earnings (TTM)-CN¥67.32m
Revenue (TTM)CN¥91.46m

7.4x

P/S Ratio

-10.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002750 income statement (TTM)
RevenueCN¥91.46m
Cost of RevenueCN¥40.94m
Gross ProfitCN¥50.52m
Other ExpensesCN¥117.83m
Earnings-CN¥67.32m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 28, 2024

Earnings per share (EPS)-0.17
Gross Margin55.24%
Net Profit Margin-73.60%
Debt/Equity Ratio1.9%

How did 002750 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.